263 related articles for article (PubMed ID: 22136837)
41. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
43. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
[TBL] [Abstract][Full Text] [Related]
44. Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A.
Puñales MK; da Rocha AP; Meotti C; Gross JL; Maia AL
Thyroid; 2008 Dec; 18(12):1261-8. PubMed ID: 18991485
[TBL] [Abstract][Full Text] [Related]
45. [Medullary thyroid carcinoma].
Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
[TBL] [Abstract][Full Text] [Related]
46. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
47. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
Machens A; Ukkat J; Hauptmann S; Dralle H
Arch Surg; 2007 Mar; 142(3):289-93; discussion 294. PubMed ID: 17372055
[TBL] [Abstract][Full Text] [Related]
48.
Souteiro P; Gouveia P; Ferreira G; Belo S; Costa C; Carvalho D; Duarte H; Sampaio IL
Endocrine; 2019 May; 64(2):322-329. PubMed ID: 30684230
[TBL] [Abstract][Full Text] [Related]
49. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
Papapetrou PD; Polymeris A
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines.
Rohmer V; Vidal-Trecan G; Bourdelot A; Niccoli P; Murat A; Wemeau JL; Borson-Chazot F; Schvartz C; Tabarin A; Chabre O; Chabrier G; Caron P; Rodien P; Schlumberger M; Baudin E;
J Clin Endocrinol Metab; 2011 Mar; 96(3):E509-18. PubMed ID: 21190982
[TBL] [Abstract][Full Text] [Related]
51. Medullary thyroid carcinoma.
Pacini F; Castagna MG; Cipri C; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
[TBL] [Abstract][Full Text] [Related]
52. Usefulness of preoperative serum calcitonin in patients with nodular thyroid disease without suspicious history or cytology for medullary thyroid carcinoma.
Rosário PW; Penna GC; Brandão K; Souza BÉ
Arq Bras Endocrinol Metabol; 2013 Jun; 57(4):312-6. PubMed ID: 23828436
[TBL] [Abstract][Full Text] [Related]
53. [Calcitonin determination for early diagnosis of medullary thyroid cancer].
Karges W
Chirurg; 2010 Jul; 81(7):620, 622-6. PubMed ID: 20549176
[TBL] [Abstract][Full Text] [Related]
54. Treatment evaluation, follow-up and familial screening of medullary thyroid carcinoma by highly specific calcitonin measurements.
Ainahi A; Kebbou M; Timinouni M; Benabdeljalil N; Oufara S
Indian J Cancer; 2006; 43(2):75-9. PubMed ID: 16790944
[TBL] [Abstract][Full Text] [Related]
55. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
[TBL] [Abstract][Full Text] [Related]
56. Different outcomes in sporadic versus familial medullary thyroid cancer.
Saltiki K; Simeakis G; Anagnostou E; Zapanti E; Anastasiou E; Alevizaki M
Head Neck; 2019 Jan; 41(1):154-161. PubMed ID: 30548085
[TBL] [Abstract][Full Text] [Related]
57. Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancer.
Machens A; Dralle H
Best Pract Res Clin Endocrinol Metab; 2019 Aug; 33(4):101274. PubMed ID: 31043326
[TBL] [Abstract][Full Text] [Related]
58. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
[TBL] [Abstract][Full Text] [Related]
60. Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India.
Mehrotra PK; Mishra A; Mishra SK; Agarwal G; Agarwal A; Verma AK
World J Surg; 2011 Jun; 35(6):1273-80. PubMed ID: 21479684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]